The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global buccal drug delivery system market is expected to grow from $2.97 billion in 2022 to $2.97 billion in 2023 at a compound annual growth rate (CAGR) of 10.8%. The buccal drug delivery systems market is expected to grow to $4.76 billion in 2027 at a CAGR of 9.7%.

North America held the largest buccal drug delivery system market share.

Buccal Drug Delivery System Market Driver
The increased prevalence of chronic diseases is projected to boost the buccal medication delivery systems market ahead in the coming years. Cancer, heart disease, stroke, diabetes, cancer, and arthritis are examples of chronic diseases that last a year or more. These are the most common chronic illnesses, which can be controlled but not cured and require ongoing nutrition and medical care. Buccal drug delivery systems enable adequate and effective drug delivery for giving mucosal and transmucosal medications, which are required by many patients with chronic conditions such as diabetes and cancer. According to a study report released by the American Action Forum in September 2020, chronic illness frequency and costs are increasing in the United States. Chronic illness is expected to rise further as the incidence of illness among children and adolescents rises. Chronic illness is a significant healthcare concern since it costs the United States $3.7 trillion per year, or nearly 19.6% of GDP, and is on the rise. As a result, the increased prevalence of chronic diseases drives the market for buccal drug delivery systems.

View More On The Buccal Drug Delivery System Market Report 2023 – https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Prominent Buccal Drug Delivery System Market Trend
In the buccal drug delivery systems market, investments in injectable drug delivery systems are a prominent trend that is gaining traction. To maintain their market position, major pharmaceutical corporations are investing in drug delivery methods. For example, Novartis, a Swiss pharmaceutical corporation, will invest around $40 million in Credence MedSystems, a US-based startup that develops new drug delivery systems, in September 2021. The investment aims to increase the production of injectable medicine delivery devices.

Buccal Drug Delivery System Market Prominent Players
Major players in the buccal drug delivery system market are Teva Pharmaceuticals Limited, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior Pharmaceuticals, Generex Biotechnology, Catalent, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, MedLab, AstraZeneca, F. Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, and Novo Nordisk A/S.

Request A Sample Of The Global Buccal Drug Delivery System Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp

Key Buccal Drug Delivery System Market Segments
The global buccal drug delivery system market is segmented –
1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

The Buccal Drug Delivery System Global Market Report 2023  provides a comprehensive overview on the buccal drug delivery system market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Drug Delivery Devices Global Market Report 2023
Drug Screening Global Market Report 2023
Drug Discovery Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model